Catapult CT awards £900K contract to Cellular Origins for robotic platform

Catapult Cell and Gene Therapy has awarded a £900,000 contract to Cellular Origins Ltd to develop a Constellation robotic platform for cell therapy manufacturing. The platform will provide incubation and bioreactor transport with modular extension capabilities.

“The Platform will deliver a version of the Constellation platform to transform cell therapy manufacturing that offers baseline functionality of incubation and bioreactor transport.”tenderline.uk

• 1 source
• tenderline.ukConstellation Robotic Platform for CGCT pre-GMP Advanced Therapies Digital & Automation Productivity Testbed: direct award to Cellular Origins Ltd [#044e2d] · TenderlineCatapult CTMar 28, 2024

Summarized from public sources; check the original articles before acting on it.